NBIX offering. ANTH files shelf.

Jan 18, 2012 No Comments by

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it is offering to sell shares of its common stock in an underwritten public offering.

Anthera Pharmaceuticals, Inc (Nasdaq: ANTH) filed a shelf today allowing it to sell from time to time a combination of stock and warrants up to $100m. This replaces its $75m shelf filed in March 2010. The change has been noted in the Financial Database.




Daily News

About the author

Currently residing in New Zealand, Mr. A.Burden holds a Master of Commerce in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.
No Responses to “NBIX offering. ANTH files shelf.”

Leave a Reply